We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Singapore, Singapore

ESTRO meets Asia 2026

Session

Friday
August 28
11:30 - 12:30
Garnet
Urological cancer
Barbara Alicja Jereczek-Fossa, Italy;
Vedang Murthy, India
Proffered Papers
Clinical Practice
11:30 - 12:30
Efficacy and Safety of Targeted-Immunotherapy With or Without Stereotactic Ablative Radiotherapy for Recurrent/Metastatic Renal Cell Carcinoma: A Multi-Center Cohort Study
Ke Hu, China
-96
11:30 - 12:30
⁶⁸GA-NY096 CAIX PET/CT ELIMINATES DECISION UNCERTAINTY AND REFINES SYSTEMIC THERAPY–RADIOTHERAPY INTEGRATION IN METASTATIC CCRCC (NYCRRT STUDY)
Mingwei Ma, China
-117
11:30 - 12:30
External validation of the FLAME risk model in POP-RT trial data and its extension to whole pelvic radiotherapy
Uulke van der Heide, The Netherlands
-282
11:30 - 12:30
Questioning androgen deprivation in prostate brachytherapy monotherapy: ADT Versus no ADT — long-term follow-up
Alai Goñi Ramirez, Spain
-22
11:30 - 12:30
Adjuvant Docetaxel Following Radiotherapy Plus Long-Term ADT for Grade Group 5 Non-Metastatic Prostate Cancer: A Prospective, Comparative Cohort Study
Mingwei Ma, China
-116
11:30 - 12:30
Interim analysis from the SNIPER trial of ultrahypofractionated prostate and pelvic radiotherapy
Wee Loon Ong, Australia
-466